Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1993-12-23
pubmed:abstractText
Hepatocellular carcinoma (HCC) is a common malignancy worldwide with limited effective therapeutic options available or appropriate for cirrhotic patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3202-9
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:7694787-Adult, pubmed-meshheading:7694787-Aged, pubmed-meshheading:7694787-Aged, 80 and over, pubmed-meshheading:7694787-Carcinoma, Hepatocellular, pubmed-meshheading:7694787-Chemoembolization, Therapeutic, pubmed-meshheading:7694787-Doxorubicin, pubmed-meshheading:7694787-Ethiodized Oil, pubmed-meshheading:7694787-Female, pubmed-meshheading:7694787-Gastrointestinal Hemorrhage, pubmed-meshheading:7694787-Gelatin Sponge, Absorbable, pubmed-meshheading:7694787-Humans, pubmed-meshheading:7694787-Injections, Intra-Arterial, pubmed-meshheading:7694787-Length of Stay, pubmed-meshheading:7694787-Liver Neoplasms, pubmed-meshheading:7694787-Male, pubmed-meshheading:7694787-Middle Aged, pubmed-meshheading:7694787-Necrosis, pubmed-meshheading:7694787-Neoplasm Recurrence, Local, pubmed-meshheading:7694787-Palliative Care, pubmed-meshheading:7694787-Prognosis, pubmed-meshheading:7694787-Remission Induction, pubmed-meshheading:7694787-Survival Rate
pubmed:year
1993
pubmed:articleTitle
Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization.
pubmed:affiliation
Department of Medicine, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II